WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced the recent launch of a new national advertising campaign to raise awareness of the UroLift® System, the leading minimally invasive, outpatient treatment in the United States for enlarged prostate, also known as benign prostatic hyperplasia (BPH). The racetrack-themed “Pit Stop” campaign takes a humorous approach and emphasizes the need to “take care of #1.” The campaign can be viewed at UroLift.com.
BPH is a non-cancerous enlargement of the prostate that occurs naturally for some men as they age. The enlarged prostate can press on and block the urethra, causing bothersome urinary symptoms, including frequency and urgency, and interrupted sleep.1
The new campaign consists of nationally televised spots and related digital ads connecting viewers to UroLift.com to learn more about the minimally invasive treatment option for an enlarged prostate.
“So many men are still putting off a visit to their urologist about their BPH despite suffering from symptoms and putting their bladder health at risk,” said Steven Gange, M.D., F.A.C.S., of Summit Urology Group and Associate Medical Director of the Teleflex Interventional Urology Business Unit. “The UroLift® System is an effective minimally invasive treatment that can provide rapid relief of BPH symptoms, and may free men from taking ongoing medications.”2
“We are excited to help raise awareness of BPH and the UroLift® System as the number one minimally invasive treatment solution of choice for urologists and their patients in the U.S., with more than 400,000 men treated around the world,” said Bryan Holmes, Global Vice President, Marketing and Business Development of the Teleflex Interventional Urology Business Unit.3-4
- No instances of new sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.
References:
- Speakman, BJUI 2014.
- Roehrborn, Can J Urol 2017.
- U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22 FINAL), which is in part based on Symphony Health PatientSource® 2018–21, as is and with no representations/warranties, including accuracy or completeness.
- Management estimate based on product sales as of December 2022. Data on file, Teleflex Interventional Urology.
- Shore, Can J Urol 2014.
- Rukstalis, Prostate Cancer and Prostatic Dis 2018.
- AUA BPH Guidelines 2003, 2021.
- McVary, Urology 2019.
- Roehrborn, J Urol 2013.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.